Nile Misr Healthcare platform is structured on the strong investment and medical expertise of the two partners
Image used for illustrative purpose. A medical staff worker is seen at Sharm International Hospital, amid the coronavirus disease (COVID-19) outbreak, in Sharm el-Sheikh, Egypt June 19, 2020.
REUTERS/Mohamed Abd El Ghany
By Staff Writer, Arab Finance
ArabFinance: Misr Capital Investments, the investment arm of Banque Misr, launched Nile Misr Healthcare platform in collaboration with Elevate Private Equity, the strategic manager of Nile Scans and Labs, a recent press release showed.
The platform’s total investment reached $380 million.
Nile Misr Healthcare platform is structured on the strong investment and medical expertise of the two partners, who will actively manage the fund strategy and acquire targets with strong potential across healthcare verticals spanning hospitals, diagnostic facilities, pharmaceuticals, medical education, and digital medical services among others in Egypt and Sub-Saharan Africa.
The platform managers aim to reach the first closing of the fund with $150 million by the end of the first quarter of 2022 with an initial investment from Banque Misr and Elevate Private Equity.
Tarek Moharram, the CEO of Elevate Private Equity, will hold the CEO position of the platform.
The platform is expected to enter its first sale and purchase agreement (SPA) within weeks upon the completion of all necessary approvals.
Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.